Literature DB >> 19686870

Allergen-induced asthma in C57Bl/6 mice: hyper-responsiveness, inflammation and remodelling.

Valentina Pinelli1, Cinzia L Marchica, Mara S Ludwig.   

Abstract

The relationship among airway responsiveness, inflammation and remodelling in asthma is incompletely understood. To investigate potential mechanistic associations, allergen-induced asthma was studied in C57Bl/6 mice. Mice were sensitized and challenged with ovalbumin (OVA) using sub-acute (SA) or chronic (C) protocols. Responsiveness was assessed by measuring respiratory impedence which was partitioned into airway resistance (Raw) and distal lung components (Gti, Hti) during methacholine-induced constriction. Inflammation, airway mucus, airway smooth muscle, collagen, biglycan and decorin were quantified. The airways were sub-divided into central or peripheral. In SA and C OVA, Raw, Gti and Hti responsiveness were significantly increased; the peripheral response was significantly greater in SA vs C OVA. Airway inflammation and mucus were increased in both groups, but more significantly in peripheral airways in SA OVA. In the SA OVA model, inflammation and mucus appear to drive the mechanical response, especially in the lung periphery; airway remodelling seems to contribute to hyper-responsiveness to an equivalent degree, after both challenge protocols.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19686870     DOI: 10.1016/j.resp.2009.08.005

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  9 in total

1.  Anti-Asthmatic Effects of Ginsenoside Rb1 in a Mouse Model of Allergic Asthma Through Relegating Th1/Th2.

Authors:  Tong Chen; Lu Xiao; Lingpeng Zhu; Shiping Ma; Tianhua Yan; Hui Ji
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

2.  Anti-inflammatory effects of apigenin in lipopolysaccharide-induced inflammatory in acute lung injury by suppressing COX-2 and NF-kB pathway.

Authors:  Jing Wang; Yu-Tao Liu; Lu Xiao; Lingpeng Zhu; Qiujuan Wang; Tianhua Yan
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

3.  Formononetin inhibited the inflammation of LPS-induced acute lung injury in mice associated with induction of PPAR gamma expression.

Authors:  Zhanqiang Ma; Weiwei Ji; Qiang Fu; Shiping Ma
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

4.  Astragalin Attenuates Allergic Inflammation in a Murine Asthma Model.

Authors:  Jiping Liu; Yue Cheng; Xiaoshuang Zhang; Xue Zhang; Shuxian Chen; Zongmiao Hu; Chunmei Zhou; Enhu Zhang; Shiping Ma
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

5.  Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation.

Authors:  Amarjit S Naura; Mourad Zerfaoui; Hogyoung Kim; Zakaria Y Abd Elmageed; Paulo C Rodriguez; Chetan P Hans; Jihang Ju; Youssef Errami; Jiwon Park; Augusto C Ochoa; A Hamid Boulares
Journal:  J Immunol       Date:  2010-07-28       Impact factor: 5.422

Review 6.  Key mediators in the immunopathogenesis of allergic asthma.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Int Immunopharmacol       Date:  2014-06-13       Impact factor: 4.932

Review 7.  Biglycan: a multivalent proteoglycan providing structure and signals.

Authors:  Madalina V Nastase; Marian F Young; Liliana Schaefer
Journal:  J Histochem Cytochem       Date:  2012-07-20       Impact factor: 2.479

8.  Divergent modulation of Rho-kinase and Ca(2+) influx pathways by Src family kinases and focal adhesion kinase in airway smooth muscle.

Authors:  Yasin Shaifta; Nneka Irechukwu; Jesus Prieto-Lloret; Charles E MacKay; Keisha A Marchon; Jeremy P T Ward; Greg A Knock
Journal:  Br J Pharmacol       Date:  2015-10-23       Impact factor: 8.739

9.  Gelam honey attenuates ovalbumin-induced airway inflammation in a mice model of allergic asthma.

Authors:  Nur Salme Suhana Shamshuddin; Rozaini Mohd Zohdi
Journal:  J Tradit Complement Med       Date:  2016-11-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.